Search for: "Medical Logic, Inc." Results 61 - 80 of 483
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Aug 2021, 10:33 am by Eugene Volokh
" I think this logic applies to statements about medical science as well as social science. [read post]
20 Aug 2021, 10:21 am by Rebecca Tushnet
D’artagnan, Inc., 2021 WL 1138017, No. 19-CV-6158 (MKB) (E.D.N.Y. [read post]
24 Jul 2021, 11:51 am by admin
There may be difficulty in the apportionment of some elements of damages, such as the pain and suffering resulting from the two wounds, or the medical expenses, but this does not mean that one defendant must be liable for the distinct harm inflicted by the other. [read post]
8 Jul 2021, 7:11 pm by Vercammen Law
During oral argument, plaintiff's attorney confirmed that no statutory or regulatory violation had been or could be asserted, that plaintiff had only a medical negligence claim for the alleged treatment Burns received at Care One, and that he anticipated his experts may refer to a breach of statutes or regulations as evidence of the applicable standard of care. [read post]
29 Jun 2021, 11:41 am by Matt Murphy
This problem of disproportion argument is logically strong, but also gets into the weeds regarding the medical science of the Guides. [read post]
14 Jun 2021, 11:16 am by Eugene Volokh
Unlike those cases, McBrayer's medical practice is not located in the wrong place; it is located in a commercial office park, zoned for medical practices, and which contains other medical practices…. [read post]
21 Apr 2021, 7:43 am by Joel R. Brandes
Recent LegislationLaws of 2021, Ch 56Laws of 2021, Ch 56, Part L § 4 to § 14 amended the Family Court Act as follows. [read post]
15 Dec 2020, 8:30 am by Eugene Volokh
[The same logic could apply when churches, synagogues, mosques, bookstores, gun stores, fur stores, and similar places are targeted by their enemies. [read post]
20 Aug 2020, 9:48 am by Lyle Roberts
Securities class actions brought against drug development and medical device companies often are based on alleged misrepresentations related to the regulatory approval process. [read post]